Add BrightSurf on Google Email

Science News for August 26, 2012


Merging the biological and the electronic

Harvard scientists developed a method to grow 'cyborg' tissues by embedding nanoscale wires into engineered human tissues. They successfully seeded the networks with cells and encouraged them to grow in 3D cultures, enabling real-time monitoring and control of living systems.

SourceHarvard University·JournalNature Materials·DateAug 26, 2012

A lesson in sleep learning

A Weizmann Institute study found that people can learn new information while sleeping and retain it unconsciously, modifying their waking behavior. The research used a type of conditioning involving tones and odors presented during sleep, leading to responses similar to those experienced when awake.

SourceWeizmann Institute of Science·JournalNature Neuroscience·DateAug 26, 2012

Pitt: Targeted oxidation-blocker prevents secondary damage after traumatic brain injury

Researchers developed an agent that blocks cardiolipin oxidation, preventing cell death and preserving function in rats with severe traumatic brain injury. The study suggests a targeted oxidation-blocker may also be beneficial in treating other neurological disorders such as Parkinson's disease and stroke.

Anti-clotting drugs yield similar results

A new study found no significant difference between prasugrel and clopidogrel in preventing death, heart attack, or stroke in ACS patients who do not undergo coronary stenting or bypass surgery. However, prasugrel showed a lower risk of recurrent adverse events after 12 months of treatment.

SourceDuke University Medical Center·JournalNew England Journal of Medicine·DateAug 26, 2012

The Aldo-DHF study

The Aldo-DHF study found that spironolactone significantly improved diastolic function and reduced blood pressure in patients with symptomatic diastolic heart failure. However, it did not improve exercise capacity or quality of life. The treatment also induced reverse cardiac remodelling and reduced left ventricular hypertrophy.

Weighing molecules 1 at a time

A team of researchers has developed a nanomechanical device that can weigh individual molecules, enabling biologists to study viruses and probe molecular machinery. The device uses vibrational modes to determine particle mass and position, opening doors for biomedical applications such as disease diagnosis and immune system monitoring.

SourceCalifornia Institute of Technology·JournalNature Nanotechnology·DateAug 26, 2012

Compounds activate key cancer enzyme to interfere with tumor formation

Researchers have identified molecular compounds that activate a key enzyme, PKM2, which governs how cancer cells use glucose and its metabolites. These compounds delay the formation of tumors in mice by correcting the altered metabolic state of cancer cells, providing a potential therapeutic strategy for cancer treatment.